grant

Prevention of catheter related infections via photoactive nitric oxide delivery device

Organization UNIVERSITY OF GEORGIALocation ATHENS, UNITED STATESPosted 1 Aug 2023Deadline 30 Apr 2027
NIHUS FederalResearch GrantFY2025AdhesionsAnti-Bacterial AgentsAntibiotic AgentsAntibiotic DrugsAntibioticsAnticoagulationAntimicrobial EffectAntisepticsBacteremiaBacteriaBacterial InfectionsBindingBioreactorsBloodBlood CirculationBlood PlateletsBlood Reticuloendothelial SystemBlood VesselsBlood-Borne PathogensBloodborne PathogensBloodstreamCatheter-related bloodstream infectionCathetersCell BodyCell LineCellLineCellsCessation of lifeClinicalClottingCoagulationCoagulation ProcessConsciousConsciousnessDeathDevelopmentDevice DesignsDevicesDisinfectionDomestic RabbitEmbolismEmbolusEndogenous Nitrate VasodilatorEndothelium-Derived Nitric OxideExposure toFiber OpticsGenerationsGoalsHealth Care CostsHealth Care IndustryHealth CostsHeparinHeparinic AcidHourImmobilizationImplantable CathetersIn VitroIn-Dwelling CathetersIndwelling CatheterInfectionInfection preventionIntensive Care UnitsK pneumoniaeK. pneumoniaeKlebsiella pneumoniaeLeadLengthLifeLocal Anti-Infective AgentsMarrow plateletMeasuresMedicalMedical DeviceMicrobial BiofilmsMiscellaneous AntibioticModelingMolecular InteractionMononitrogen MonoxideN-acetylpenicillamineNitric OxideNitric Oxide DonorsNitrogen MonoxideNitrogen ProtoxideObstructionOryctolagus cuniculusP aeruginosaP. aeruginosaPatient CarePatient Care DeliveryPatientsPb elementPeripheralPhysiologicPhysiologicalPlatelet ActivationPlateletsPolymersPrevent infectionPreventionPropertyPseudomonas aeruginosaPseudomonas pyocyaneaR-Series Research ProjectsR01 MechanismR01 ProgramRabbitsRabbits MammalsResearch GrantsResearch Project GrantsResearch ProjectsRiskS aureusS epidermidisS-NitrosothiolsS. aureusS. epidermidisSafetySideStaph aureusStaphylococcus aureusStaphylococcus epidermidisSterilizationStrains Cell LinesSurfaceTechnologyTestingTherapeuticThrombocytesThrombosisThrombusTopical Anti-Infective AgentsTranslationsUnited StatesVascular Endothelial CellVenousVenous ReservoirsWorkanalytical methodanti-bacterialanti-microbialanti-microbial effectantimicrobialbacteraemiabacteria infectionbacterial bloodstream infectionbacterial diseasebacterial infection in the bloodstreambiocompatibilitybiofilmbiomaterial compatibilitybiomedical implantblood infectionbloodstream infectioncare for patientscare of patientscaring for patientscatheter related infectionclinical applicabilityclinical applicationclinical translationclinically translatablecostcovalent bondcultured cell linedata integrationdevelopmentalearly clinical trialearly phase clinical trialendothelial cell derived relaxing factorheavy metal Pbheavy metal leadhemocompatibilityimplant deviceimplantable deviceimprovedin vitro Bioassayindwelling deviceinfection in the bloodinfection of the bloodmicrobialmicrobioreactormigrationorthopedic freezingphotoactivationpolymerpolymericportabilitypreventpreventingsuccessthromboembolic complicationsthrombosis complicationsthromboticthrombotic complicationsthrombotic diseasethrombotic disordertranslationvascular
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary/Abstract
Currently, clinical applications of intravascular catheters suffer from major challenges: 1) infection; and 2) platelet

activation and surface-induced thrombosis. Bacterial contamination of catheters causes more than 28,000

deaths per year in the United States, as well as costing the healthcare industry a staggering $2.3 billion.

Thrombus formation can further lead to obstruction of blood vessels, catheter malfunction, or even life-

threatening situations such as embolism. Commercial catheters with heparin-bonded surfaces are available to

prevent clotting, but do little to prevent infections. In addition, antiseptics or antibiotics catheter coatings or lock

solutions decrease the risk of bacterial infection, but do not prevent biofilm formation that shields bacteria from

antibiotics. Therefore, there is a necessity and opportunity to develop device strategies for preventing infection

and thrombosis on indwelling catheters for enhanced patency and safety.

Our work and others have demonstrated that nitric oxide (NO) release from polymer surfaces can prevent platelet

activation and bacterial infection. This technology mimics the vascular endothelial cells lining the blood vessels,

as well as other cells in our bodies, producing NO locally to prevent clotting and bacterial biofilm. Recently we

discovered that all of the positive effects can be achieved from polymers physically blended with the NO donor

molecule S-nitroso-N-acetylpenicillamine (SNAP), which is nontoxic, inexpensive, and easy to synthesize.

Active NO release from the NO donors in polymers reduces infection and thrombosis on catheters; however, the

NO-release polymer strategy alone is limited by the finite reservoir of NO donor functionalities within the catheter

wall which limits the duration of the NO availability/release. Our recent work has shown the potential of

developing a catheter hub device that utilizes photoactive NO-releasing polymers with side glowing fiber optics

that enables controllable NO release levels. The goal of this proposal is to develop a catheter hub device

comprised of a polymer utilizing a NO donor covalently bonded to the polymer with side glowing fiber

optics to provide photoactive NO-release (without leaching) to provide long-term, tunable NO-release at

the catheter interface to provide potent broad-spectrum antimicrobial properties and reduce thrombosis

by inhibiting platelet adhesion/activation. The new device will be applicable to any catheter device; however,

this proposal will focus on studying the combined photoactive NO-releasing catheter hub device in long-term

intravascular catheters for the prevention of infection and thrombosis. Successful completion of this project will

allow progression to early clinical trials and the development of a new generation of devices that can be inserted

within the lumen of indwelling catheters to prevent these complications while improving patient care.

Grant Number: 5R01HL170574-03
NIH Institute/Center: NIH

Principal Investigator: Elizabeth Brisbois

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →